WebA reduction of low-density lipoprotein cholesterol (LDL-C) is important for the secondary prevention of coronary artery disease. We performed secondary prevention in 632 consecutive patients, including 315 with acute coronary syndrome, who underwent percutaneous coronary intervention according to current treat-to-target lipid-lowering … Web3 Oct 2024 · This study population consisted of 500 patients, of which 150 were statin eligible for primary prevention and 350 were statin eligible for secondary prevention. The proportion of males in the total study population (n = 500) was higher (68%), 70% of patients had a prior history of CVD. Hypertension and diabetes mellitus were the leading CVD ...
Coronary Heart Disease and Stroke, Primary and Secondary Prevention …
WebObjective: To estimate the relative risk reduction of the clinical outcomes (coronary events, strokes, cardiovascular, non-cardiovascular and all-cause mortality) associated with statin therapy in primary and secondary prevention. Data sources: A literature search of the Medline and Cohrane databases for articles published from 1985 to July 2002 was … WebA statin is recommended as the lipid-lowering drug of choice for secondary prevention of CVD. Factors such as polypharmacy, frailty, and comorbidities should be taken into … skonewood christian retreat cushing wi
Peripheral arterial disease: diagnosis and management
WebObjective To determine the risk of cardiovascular events and death in patients receiving statin treatment for cholesterol regulation.. Methods Systematic review and meta-analysis of all randomized controlled trials that were published as of April 15, 1997. Primary or secondary prevention trials or regression trials were eligible. Main Outcome Measures All … WebFor secondary prevention, patients should be offered treatment with an angiotensin-converting enzyme (ACE) inhibitor, a beta-blocker, dual antiplatelet therapy (unless they have a separate indication for anticoagulation—see below), and a statin. A Strength of recommendation: High. Web15 Jun 2007 · Recent major statin trials in primary and secondary prevention have demonstrated a pattern of approximately 1% decrease in coronary events for each 1% decline in LDL-C . 1–5 Three different models linear, curvilinear, and threshold) have been proposed for the relationship between LDL-C levels and coronary risk, all of which have … skonewood cushing wi